Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH3 | Q9ULD8 | 6/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9008390 | 0.80 | SLC29A1 (0.38) | KCNH3CYP1A2CYP2C19TSHRSLC29A1 | |
| SCHEMBL9008416 | 0.73 | SLC29A1 (0.50) | KCNH3SLC29A1KMT2AGBA1 | |
| SCHEMBL9008414 | 0.73 | HTR7 (0.39) | TSHRKMT2A | |
| SCHEMBL6575534 | 0.73 | ESR1 (0.39) | KCNH3CYP1A2CYP2C19KMT2A | |
| SCHEMBL9505742 | 0.72 | TSHR (0.41) | KCNH3TSHRSLC29A1KMT2A | |
| SCHEMBL8029566 | 0.72 | CYP2C19 (0.35) | CYP1A2CYP2C19TSHRKMT2A | |
| SCHEMBL11345327 | 0.71 | KCNH3 (0.64) | KCNH3CYP1A2CYP2C19TSHRKMT2A | |
| SCHEMBL3842708 | 0.71 | MAPT (0.57) | KCNH3CYP1A2CYP2C19KMT2A | |
| SCHEMBL1120392 | 0.70 | HTR2A (0.40) | — | |
| SCHEMBL9008403 | 0.70 | TLR8 (0.39) | TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0817776-B1 | FORMALDEHYDE-FREE 1,3,5-TRIAZINE BASED CROSSLINKERS | CYTEC TECH CORP (US) | 2004-05-06 | — | — | EP | disclosed |
| US-5783642-A | Coating compositions containing 1,3,5-triazine compounds substituted with acetal and/or cyclized acetal-based groups | CYTEC INDUSTRIES INC. (US) | 1998-07-21 | — | — | US | disclosed |
| US-5777040-A | Curable compositions containing 1,3,5-triazine compounds substituted with acetal and/or cyclized acetal-based groups | CYTEC TECHNOLOGY CORP. (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0817776-A1 | FORMALDEHYDE-FREE 1,3,5-TRIAZINE BASED CROSSLINKERS | CYTEC TECHNOLOGY CORP. (US) | 1998-01-14 | — | — | EP | disclosed |
| US-5672703-A | CURING AGENTS | CYTEC TECHNOLOGY CORP. (US) | 1997-09-30 | — | — | US | disclosed |
| WO-1996029318-A1 | FORMALDEHYDE-FREE 1,3,5-TRIAZINE BASED CROSSLINKERS | CYTEC TECHNOLOGY CORP. (US) | 1996-09-26 | — | — | WO | disclosed |